Simon Thompson 

Alpha: Simon Thompson spies opportunity in cutting edge technology

Alpha: Simon Thompson spies opportunity in cutting edge technology

This small-cap London-based company is well under the radar of most investors, but it is highly regarded by major players in the pharmaceutical and biotechnology industries. The business has developed artificial intelligence (AI) software algorithms that have become highly valued by huge corporations looking to develop cures for serious neurological ailments.   

To continue reading, subscribe to Alpha today

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now